Sign Up Now!

Sign up and get personalized intelligence briefing delivered daily.


Sign Up

Articles related to "patient"


Facebook is trying to use AI to make MRI scans ten times faster

  • The social networking giant announced on Monday a new research project that aims to use artificial intelligence (AI) to make MRI scans up to ten times faster, and has been granted access to a trove of around 3 million anonymised MRI images from 10,000 clinical cases.
  • In an announcement blog post, Facebook said the data it has accessed has had patient names removed, as well as "all other protected health information," and the project is compliant with HIPAA privacy regulations.
  • DeepMind, an AI lab owned by Google faced years of scrutiny over a data-sharing partnership with Britain's NHS (National Health Service), and the UK's data regulator ultimately ruled that the organisation violated British privacy laws.
  • There was also uproar earlier this year after CNBC reported that Facebook had been talking to hospitals about sharing data on patients, and the company subsequently said the project had been put on hold.

save | comments | report | share on


Facebook is trying to use AI to make MRI scans ten times faster

  • The social networking giant announced on Monday a new research project that aims to use artificial intelligence (AI) to make MRI scans up to ten times faster, and has been granted access to a trove of around 3 million anonymised MRI images from 10,000 clinical cases.
  • In an announcement blog post, Facebook said the data it has accessed has had patient names removed, as well as "all other protected health information," and the project is compliant with HIPAA privacy regulations.
  • DeepMind, an AI lab owned by Google faced years of scrutiny over a data-sharing partnership with Britain's NHS (National Health Service), and the UK's data regulator ultimately ruled that the organisation violated British privacy laws.
  • There was also uproar earlier this year after CNBC reported that Facebook had been talking to hospitals about sharing data on patients, and the company subsequently said the project had been put on hold.

save | comments | report | share on


A company that calls itself the 'Flatiron Health of rare diseases' and is backed by Mark Zuckerberg, Bill Gates, and Jeff Bezos just raised $3 million

  • When Onno Faber was diagnosed in 2014 with a rare disease called neurofibromatosis type 2 that creates tumors in the central nervous system, he blindly combed through the Internet for treatment options before a friend who was doing genetic research suggested a potential clinical trial.
  • Faber likens RDMD to the "Flatiron Health of rare diseases" since it provides a searchable database for patients, researchers and doctors that makes patient data usable for research and drug development purposes.
  • The problem in the rare disease sector is that there aren't that many doctors, patients or researchers so it takes a long time to collect enough clinical data to do research.
  • The goal of RDMD is to create a platform that can shorten the timeline for research and development of treatments for rare disease.

save | comments | report | share on


A $50 Genetic Test Can Tell How Likely You Are to Have a Heart Attack

  • Now a team of researchers wants to build a website that will use genetic data to determine your risk of developing five serious health conditions, including heart disease and type 2 diabetes.
  • Next, they developed an algorithm that could use all this information on a disease’s genetic variants to produce a polygenic risk score, a single number that would indicate a person’s risk of developing each disease based on their genomic data.
  • This isn’t the first study to consider using genetics to prevent future health issues; healthcare providers across the globe are starting to consider making genetic testing a routine part of general patient care.
  • For now, Kathiresan is discussing his proposed polygenic risk score website with commercial providers, and he hopes to eventually expand his algorithm to identify more diseases.

save | comments | report | share on


RDMD attacks rare diseases with data mined from health records

  • It’s like Flatiron Health, the Google-backed cancer data startup that just got bought for $2 billion, but for rare diseases.
  • But “RDMD generates research-grade, regulatory-grade data from patient medical records for use in rare disease drug R&D” says Yu. The more data it can collect, the more pharma companies can do to help patients.
  • But the potential to expand to other rare diseases attracted a previous pre-seed round from Village Global and new funding from angels like Clover Health CEO and Flatiron board member Vivek Garipalli, Flatiron investor and GV (Google Ventures) partner Vineeta Agarwala, Twitter CTO Parag Agrawal, former 23andme president Andy Page, and the husband and wife duo of former Instagram VP of product Kevin Weil and 137 Ventures managing director Elizabeth Weil.

save | comments | report | share on


Tech firms say A.I. can transform health care as we know it. Doctors think they should slow down

  • Just two days ago, DeepMind, an AI (artificial intelligence) firm owned by Google, said it had lent its technology to London's Moorfields Eye Hospital for groundbreaking research into detecting eye diseases.
  • Take Babylon Health for instance, which in June said its AI chatbot was able to diagnose medical conditions as accurately as a doctor.
  • The firm's chatbot scored a higher-than-average test score on the official exam set for physicians by the Royal College of General Practitioners (RCGP), an industry body representing GPs — doctors that treat a wide range of common illnesses.
  • Nevertheless, the spat highlighted a serious question that may one day need to be addressed by those in the health industry: How should health professionals respond to the rapid growth in new, data-driven technologies like AI?

save | comments | report | share on